Onco-Innovations Limited (NEO:ONCO)

Onco-Innovations Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun 18, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023
Market Capitalization	42	76	-	-
Enterprise Value	41	76	-	-
Last Close Price	0.70	1.50	-	-
PS Ratio	269.58	1164.95	-	-
PB Ratio	107.24	42.13	-	-
P/TBV Ratio	107.24	42.13	-	-
EV/Sales Ratio	262.54	1158.58	-	-
Net Debt / Equity Ratio	-1.32	-0.62	-1.40	-1.00
Asset Turnover	-	0.05	-	-
Quick Ratio	1.23	2.94	3.47	-
Current Ratio	1.87	5.41	3.47	-
Return on Equity (ROE)	-	-799.79%	-233.40%	-
Return on Assets (ROA)	-	-144.12%	-105.54%	-
Return on Capital Employed (ROCE)	-1947.20%	-170.10%	-123.50%	-1.30%
Earnings Yield	-35.79%	-11.17%	-	-
Buyback Yield / Dilution	-9693.55%	-905.82%	-	-

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error